WS Investor
30 Mar 2026, 19:59
Abbott announced a partnership with Flatiron Health to integrate its Precision Oncology portfolio into the OncoEMR® platform.
The integration enables oncologists to order diagnostic tests and access results directly within their existing clinical workflow, improving efficiency and reducing administrative burden.
The move expands access to Abbott’s oncology tests across Flatiron’s network of more than 1,600 cancer care centers and 4,700 providers in North America.
The companies said the collaboration will support faster, data-driven treatment decisions and enhance personalized cancer care by embedding diagnostics into everyday clinical practice.
PRNewswire
The integration enables oncologists to order diagnostic tests and access results directly within their existing clinical workflow, improving efficiency and reducing administrative burden.
The move expands access to Abbott’s oncology tests across Flatiron’s network of more than 1,600 cancer care centers and 4,700 providers in North America.
The companies said the collaboration will support faster, data-driven treatment decisions and enhance personalized cancer care by embedding diagnostics into everyday clinical practice.
PRNewswire
